KIRSTEN HEFRIGHT: Open Payments
NPI 1811547011 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 49 payments from 9 companies in 2025. Trend: 2023 $2,598 · 2024 $1,631 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $269 |
| Novo Nordisk Inc | 12 | $231 |
| Amgen Inc. | 8 | $135 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Exact Sciences Corporation | 3 | $52 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| Dexcom, Inc. | 1 | $23 |
| Stryker Corporation | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: QULIPTA, Ozempic, UBRELVY, Wegovy, REPATHA, Cologuard Collection Kit, KEVEYIS, EVENITY.
Industry payments across PA — which companies pay providers there.
